Mene Pangalos, AstraZeneca R&D chief (AstraZeneca via YouTube)

The FDA hands Farx­i­ga 'break­through' sta­tus in CKD, clear­ing path for As­traZeneca's much-tout­ed ther­a­py

As­traZeneca has been promis­ing big things on Farx­i­ga in kid­ney dis­ease since March, when they stopped a Phase III tri­al over what they deemed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.